China SXT Pharmaceuticals, Inc. Retained Earnings
China SXT Pharmaceuticals, Inc. (SXTC) had Retained Earnings of -$34.22 million as of 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-01
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$34.22M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$34.38M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$28.02M.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$25.51M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-03-31 | -$34.22M 20-F · filed 2026-07-01 |
| 2025-09-30 | -$34.38M 6-K · filed 2025-12-31 |
| 2025-03-31 | -$28.02M 20-F · filed 2026-07-01 |
| 2024-09-30 | -$25.51M 6-K · filed 2025-03-28 |
| 2024-03-31 | -$24.71M 20-F · filed 2025-07-31 |
| 2023-09-30 | -$31.31M 6-K · filed 2024-04-05 |
| 2023-03-31 | -$21.61M 20-F · filed 2024-08-13 |
| 2022-09-30 | -$17.18M 6-K · filed 2023-02-24 |
| 2022-03-31 | -$15.69M 20-F · filed 2023-07-31 |
| 2021-09-30 | -$13.04M 6-K · filed 2022-01-14 |
| 2021-03-31 | -$9.95M 20-F/A · filed 2023-05-19 |
| 2020-09-30 | -$5.82M 6-K · filed 2021-01-28 |
| 2020-03-31 | -$7.20M 20-F · filed 2021-08-13 |
| 2019-09-30 | $735.80K 6-K/A · filed 2020-05-22 |
| 2019-03-31 | $3.08M 20-F · filed 2020-07-31 |
| 2018-03-31 | $1.54M 20-F · filed 2019-08-15 |